Keyword: Biosimilars

News

Mundipharma to Launch Biosimilar Truxima in Europe

28.02.2017 - UK pharmaceutical group Mundipharma is gearing up to launch Truxima (rituximab), a biosimilar from South Korea’s Celltrion, for the treatment of certain cancers and inflammatory...

News

Sanofi Files Patent Suit Against US Merck

20.09.2016 - French drugmaker Sanofi has filed a patent infringement suit in the United States District Court for the District of Delaware charging US pharmaceutical producer Merck with...

Plant Construction & Process Technology

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

12.09.2016 - Dear Readers, Since the beginning of the 21st century, pharma M&A activity has exploded. In addition to mergers and acquisitions, outsourcing of research and manufacturing has...

News

Roche’s Gazyva Misses Lymphoma Target

20.07.2016 - Roche’s new blood cancer drug Gazyva has failed to show significant improvements in a late-stage lymphoma trial, delivering a blow to its plans for a successor to blockbuster drug...

News

Sandoz to Launch Five Biosimilars by 2020

21.06.2016 - Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to launch five biosimilars of major oncology and immunology biologics across key global markets by 2020...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...

News

NICE Approves Two Biosimilars for Arthritis

02.02.2016 - Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck’s and the world’s best-selling medicines...

News

Global Data Sees Indian Generics Soaring

29.01.2016 - The value of the Indian pharmaceutical market is set to nearly quadruple over the next five years, soaring from $20 billion in 2015 to $55 billion by 2020, according to GlobalData...